AKBABiotechnology / Biotechnology
Akebia Therapeutics Inc
30-Day Price
Key Metrics
Latest Close
$1.42
Market Cap
$380M
Shares Outstanding
267,880,000
P/B Ratio
13.1
ROE
-1639.00%
ROA
-142.00%
Gross Margin
8283.00%
Operating Margin
995.00%
Net Margin
-226.00%
Debt / Equity
5.94
Current Ratio
1.55
Want the full picture?
Sign up free for full analysis, strategy backtesting with credibility scoring, portfolio management, and more.
Start Free